Arcus Biosciences - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $79,679.03 +4.66%
Ethereum $3,207.83 +5.92%
BNB $638.11 +2.81%
Optimism $1.71 +6.80%
Arbitrum $0.64 +7.66%
Solana $210.22 +6.58%
Polygon $0.41 +9.07%
Cosmos $5.44 +16.19%
Avalanche $32.28 +12.09%

Bitcoin $79,679.03 +4.66%
Ethereum $3,207.83 +5.92%
BNB $638.11 +2.81%
Optimism $1.71 +6.80%
Arbitrum $0.64 +7.66%
Solana $210.22 +6.58%
Polygon $0.41 +9.07%
Cosmos $5.44 +16.19%
Avalanche $32.28 +12.09%

Arcus Biosciences

company

Investors

Number of Lead Investors

Number of Investors

3

18

Arcus Biosciences is funded by 18 investors. Gilead Sciences and GV are the most recent investors.

Investor Name	Lead Investor	Funding Round
Gilead Sciences	Yes	Post-IPO Equity
GV	Yes	Series C
Aisling Capital	-	Series C
Biotechnology Value Fund	-	Series C
Celgene	-	Series C
Decheng Capital	-	Series C
Droia Ventures	-	Series C
EcoR1 Capital	-	Series C
Foresite Capital	-	Series C
Hillhouse Capital Group	-	Series C
Invus	-	Series C
Leerink Partners	-	Series C
Taiho Ventures	-	Series C
The Column Group	-	Series C
Wellington Management	-	Series C
Novartis	-	Series B
RTA Capital	-	Series B
Stanford University	-	Series B